-
PROVIDERS
REGISTER NOW
AI in oncology: Fundamentals to full integration into your practice
Monday, September 15th
10:00am PT, 12:00pm CT, 1:00pm ET -
LIFE SCIENCES
READ NOW
Q&A: Harnessing generative AI to refine clinical research & drug development
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Original Webinar Date:
08/12/2025
What’s next in oncology: Research breakthroughs from the 2025 ASCO® annual meeting
Explore key research and clinical insights from the 2025 ASCO® Annual Meeting, featuring expert analysis from Drs. Ezra Cohen, Sara Tolaney, Nataliya Uboha, and Cynthia Ma.
Speakers
Ezra Cohen,
Chief Medical Officer of Oncology, Tempus,
Cynthia X. Ma, MD, PhD
Professor, Medicine, Division of Oncology at Washington University School of Medicine
Nataliya Uboha, MD, PhD
Faculty Leader for Early Phase Oncology Therapeutics Program, Associate Professor, Department of Medicine, Section of Hematology & Oncology, University of Wisconsin
Sara Tolaney,
Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, Associate Professor of Medicine at Harvard Medical School
Chief Medical Officer of Oncology, Tempus,
Cynthia X. Ma, MD, PhD
Professor, Medicine, Division of Oncology at Washington University School of Medicine
Nataliya Uboha, MD, PhD
Faculty Leader for Early Phase Oncology Therapeutics Program, Associate Professor, Department of Medicine, Section of Hematology & Oncology, University of Wisconsin
Sara Tolaney,
Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, Associate Professor of Medicine at Harvard Medical School
-
06/25/2024Revolutionizing Cardiac Care: AI-driven detection and treatment of critical heart valve disease at Boulder Community Health
Discover how Tempus Next's AI-powered care pathway platform transformed patient outcomes by helping ensure timely, guideline-directed treatment for critical heart valve disease at Boulder Community Health
Read more -
04/15/2024Identifying patients with Valvular Heart Disease: A partnership between St.Francis and Tempus
Learn how the deployment of Tempus Next, an AI-enabled clinical care pathway solution at St. Francis enabled guideline directed care for patients with structural heart disease.
Read more -
04/15/2024Closing the biomarker testing gap for early stage NSCLC patients with Tempus Next
Learn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio to surface and close gaps in biomarker testing for NSCLC patients.
Read more